Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.


ratings:
Length:
27 minutes
Released:
Apr 6, 2021
Format:
Podcast episode

Description

In this episode, we discuss ivermectin as a potential therapeutic for COVID-19 and review available randomized trials evaluating this drug. Chaccour et al E-Clinical Medicine Lopez-Medina et al. JAMA Schwartz et al (not yet published) IDSA guidelines NIH Treatment guidelines Show notes: FOAMcast.org Thanks for listening! Jeremy Faust and Lauren Westafer
Released:
Apr 6, 2021
Format:
Podcast episode

Titles in the series (100)

We review a cutting edge a Free Open Access Medical Education (FOAM) blog or podcast and then delve into the Emergency Medicine Core Content texts on relevant issues and end with free board review questions. We believe in the educational merits of Free Open Access Medical education (FOAM), which includes podcasts, blogs, articles on PubMed Central, conferences streamed for free and more. As a result, we would like to encourage others to move beyond quoting podcasts and into the realm of tying “cutting edge” FOAM to the core content. Why, indeed, should we FOAM it alone when FOAM can inspire us to go, read, think, and be excellent? Thanks for listening, Jeremy Faust and Lauren Westafer